(Reuters) -Novo Nordisk has partnered with India’s Emcure Pharmaceuticals to exclusively distribute and market weight-loss drug Poviztra semaglutide injection in the country, the Indian firm said on Monday.

(Reporting by Manvi Pant in Bengaluru; Editing by Mrigank Dhaniwala)

See Full Page